Beyond its marked effects on PNET cell viability, as well as its generalized effects on reversing the metastatic PNET signature, vorinostat was found to modulate tumoral CCR5 expression in vitro, a regulation that serves as the nexus of T cell migration toward metastatic PNET tissue. Here, CCR5 is linked to primitive neuroectodermal tumor.